Yoon K. Loke

ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions

Jonathan A C Sterne, Miguel A. Hernán, Barnaby C Reeves et al. · BMJ · 2016 · 19K citations · Full text

Public Health, Biostatistics, Health Services Research +15

PRISMA harms checklist: improving harms reporting in systematic reviews

Liliane Zorzela, Yoon K. Loke, John P. A. Ioannidis et al. · BMJ · 2016 · 555 citations · Full text

Public Affairs, Preventive Medicine, Good Clinical Practice +11

Anticholinergic drugs and risk of dementia: case-control study

Kathryn Richardson, Chris Fox, Ian Maidment et al. · BMJ · 2018 · 498 citations · Full text

Medicine, Geriatric Medicine, Pharmacology +8

Publication bias: what is it? How do we measure it? How do we avoid it?

Fujian Song, Lee Hooper, Yoon K. Loke · Open Access Journal of Clinical Trials · 2013 · 285 citations · Full text

Public Health, Biostatistics, Epidemiologic Methods +16

CONSORT Harms 2022 statement, explanation, and elaboration: updated guideline for the reporting of harms in randomised trials

Daniela R. Junqueira, Liliane Zorzela, Su Golder et al. · BMJ · 2023 · 249 citations · Full text

Pharmacy, Pharmacoeconomics, Clinical Epidemiology +16